All News about Curevac N.V.
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2023/05/23/cohbar_-_logo.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](/next-assets/images/schema-image-default.png)
Earnings Preview: CureVac
April 24, 2023
Via Benzinga
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://www.investors.com/wp-content/uploads/2021/12/Stock-moderna-12-adobe.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/02/17/pfizer-biontech_covid-19_vaccine_2020_g.jpg?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://cdn.benzinga.com/files/images/story/2023/02/07/vaccine-4892059.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/02/07/bbby.png?width=1200&height=800&fit=crop)
Via Benzinga
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
CureVac Announces Proposed Public Offering of Common Shares
February 07, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
CureVac Welcomes Myriam Mendila as New Chief Development Officer
February 01, 2023
Via ACCESSWIRE
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
Via ACCESSWIRE
![](https://cdn.benzinga.com/files/images/story/2023/01/30/cvac_logo_light__e5ae5d8b22b5803ccadba8057b4592e1.png?width=1200&height=800&fit=crop)
![](https://edge-cdn.isdr.io/accesswire/Accesswire_256x256.png )
![](https://investorplace.com/wp-content/uploads/2019/07/biotech1600d.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/19/image31.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/19/image27.jpeg?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For January 19, 2023
January 19, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/01/19/image_7.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/19/stock_market_photo_by_feylite_on_shutterstock.jpg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2022/10/biotechnology1600.png)
![](https://investorplace.com/wp-content/uploads/2019/08/pfe-stock-2.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/01/12/image22.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/11/image20.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/11/image-wwe.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/01/11/share_market_photo_by_vintage_tone_on_shutterstock.jpg?width=1200&height=800&fit=crop)
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.